Australia markets close in 4 hours 40 minutes

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
37.70-0.28 (-0.74%)
At close: 4:00PM EDT

37.60 -0.10 (-0.27%)
After hours: 7:47PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 592.33B
Enterprise value 3121.13B
Trailing P/E 11.95
Forward P/E 112.12
PEG ratio (5-yr expected) 12.92
Price/sales (ttm)2.71
Price/book (mrq)6.44
Enterprise value/revenue 33.55
Enterprise value/EBITDA 711.68

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 3-7.82%
S&P500 52-week change 352.13%
52-week high 343.18
52-week low 333.26
50-day moving average 335.96
200-day moving average 336.53

Share statistics

Avg vol (3-month) 36.46M
Avg vol (10-day) 38.02M
Shares outstanding 52.52B
Implied shares outstanding 6N/A
Float 2.45B
% held by insiders 10.01%
% held by institutions 112.33%
Shares short (30 Mar 2021) 427.67M
Short ratio (30 Mar 2021) 45.25
Short % of float (30 Mar 2021) 4N/A
Short % of shares outstanding (30 Mar 2021) 41.10%
Shares short (prior month 25 Feb 2021) 420.5M

Dividends & splits

Forward annual dividend rate 42.12
Forward annual dividend yield 45.58%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 32.11%
5-year average dividend yield 45.21
Payout ratio 469.30%
Dividend date 307 Apr 2021
Ex-dividend date 417 Feb 2021
Last split factor 22:1
Last split date 311 Nov 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 16.86%
Operating margin (ttm)24.88%

Management effectiveness

Return on assets (ttm)6.62%
Return on equity (ttm)32.62%

Income statement

Revenue (ttm)34.1B
Revenue per share (ttm)13.71
Quarterly revenue growth (yoy)-1.80%
Gross profit (ttm)23.21B
EBITDA 10.37B
Net income avi to common (ttm)5.75B
Diluted EPS (ttm)3.15
Quarterly earnings growth (yoy)-47.90%

Balance sheet

Total cash (mrq)6.83B
Total cash per share (mrq)2.74
Total debt (mrq)27.15B
Total debt/equity (mrq)130.48
Current ratio (mrq)0.91
Book value per share (mrq)5.86

Cash flow statement

Operating cash flow (ttm)8.44B
Levered free cash flow (ttm)8.05B